Literature DB >> 22991461

Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells.

Martin Vaeth1, Ulrike Schliesser, Gerd Müller, Sonja Reissig, Kazuki Satoh, Andrea Tuettenberg, Helmut Jonuleit, Ari Waisman, Martin R Müller, Edgar Serfling, Birgit S Sawitzki, Friederike Berberich-Siebelt.   

Abstract

Several lines of evidence suggest nuclear factor of activated T-cells (NFAT) to control regulatory T cells: thymus-derived naturally occurring regulatory T cells (nTreg) depend on calcium signals, the Foxp3 gene harbors several NFAT binding sites, and the Foxp3 (Fork head box P3) protein interacts with NFAT. Therefore, we investigated the impact of NFAT on Foxp3 expression. Indeed, the generation of peripherally induced Treg (iTreg) by TGF-β was highly dependent on NFAT expression because the ability of CD4(+) T cells to differentiate into iTreg diminished markedly with the number of NFAT family members missing. It can be concluded that the expression of Foxp3 in TGF-β-induced iTreg depends on the threshold value of NFAT rather than on an individual member present. This is specific for iTreg development, because frequency of nTreg remained unaltered in mice lacking NFAT1, NFAT2, or NFAT4 alone or in combination. Different from expectation, however, the function of both nTreg and iTreg was independent on robust NFAT levels, reflected by less nuclear NFAT in nTreg and iTreg. Accordingly, absence of one or two NFAT members did not alter suppressor activity in vitro or during colitis and transplantation in vivo. This scenario emphasizes an inhibition of high NFAT activity as treatment for autoimmune diseases and in transplantation, selectively targeting the proinflammatory conventional T cells, while keeping Treg functional.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22991461      PMCID: PMC3479579          DOI: 10.1073/pnas.1203870109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.

Authors:  Mindi R Walker; Bryan D Carson; Gerald T Nepom; Steven F Ziegler; Jane H Buckner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 2.  Transcriptional basis of lymphocyte tolerance.

Authors:  Madhuri Borde; Robert A Barrington; Vigo Heissmeyer; Michael C Carroll; Anjana Rao
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

3.  FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Kathryn Bembas; Ran Tao; Samik Basu; James L Riley; Wayne W Hancock; Yuan Shen; Sandra J Saouaf; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-07       Impact factor: 11.205

4.  NFAT and NFkappaB activation in T lymphocytes: a model of differential activation of gene expression.

Authors:  Wayne G Fisher; Pei-Chi Yang; Ram K Medikonduri; M Saleet Jafri
Journal:  Ann Biomed Eng       Date:  2006-10-10       Impact factor: 3.934

5.  Molecular mechanisms underlying FOXP3 induction in human T cells.

Authors:  Pierre-Yves Mantel; Nadia Ouaked; Beate Rückert; Christian Karagiannidis; Roland Welz; Kurt Blaser; Carsten B Schmidt-Weber
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

6.  FOXP3 controls regulatory T cell function through cooperation with NFAT.

Authors:  Yongqing Wu; Madhuri Borde; Vigo Heissmeyer; Markus Feuerer; Ariya D Lapan; James C Stroud; Darren L Bates; Liang Guo; Aidong Han; Steven F Ziegler; Diane Mathis; Christophe Benoist; Lin Chen; Anjana Rao
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

7.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

8.  TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.

Authors:  Julien C Marie; John J Letterio; Marc Gavin; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

9.  Epigenetic control of the foxp3 locus in regulatory T cells.

Authors:  Stefan Floess; Jennifer Freyer; Christiane Siewert; Udo Baron; Sven Olek; Julia Polansky; Kerstin Schlawe; Hyun-Dong Chang; Tobias Bopp; Edgar Schmitt; Stefan Klein-Hessling; Edgar Serfling; Alf Hamann; Jochen Huehn
Journal:  PLoS Biol       Date:  2007-02       Impact factor: 8.029

10.  IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo.

Authors:  Birgit Sawitzki; Cherry I Kingsley; Vanessa Oliveira; Mahzuz Karim; Manuela Herber; Kathryn J Wood
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

View more
  63 in total

1.  STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection.

Authors:  Ludovic Desvignes; Carl Weidinger; Patrick Shaw; Martin Vaeth; Theo Ribierre; Menghan Liu; Tawania Fergus; Lina Kozhaya; Lauren McVoy; Derya Unutmaz; Joel D Ernst; Stefan Feske
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

2.  Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function.

Authors:  Cesar M Rueda; Maria E Moreno-Fernandez; Courtney M Jackson; Suhas G Kallapur; Alan H Jobe; Claire A Chougnet
Journal:  Eur J Immunol       Date:  2015-06-25       Impact factor: 5.532

3.  Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP.

Authors:  Amicia D Elliott; Alessandro Ustione; David W Piston
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-11-18       Impact factor: 4.310

4.  IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.

Authors:  Gavin Whitehouse; Elizabeth Gray; Sotiris Mastoridis; Elliot Merritt; Elisavet Kodela; Jennie H M Yang; Richard Danger; Marta Mairal; Sofia Christakoudi; Juan J Lozano; Iain C Macdougall; Timothy I M Tree; Alberto Sanchez-Fueyo; Marc Martinez-Llordella
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

Review 5.  Transplant trials with Tregs: perils and promises.

Authors:  Qizhi Tang; Flavio Vincenti
Journal:  J Clin Invest       Date:  2017-06-30       Impact factor: 14.808

6.  A Novel mTORC1-Dependent, Akt-Independent Pathway Differentiates the Gut Tropism of Regulatory and Conventional CD4 T Cells.

Authors:  Leo C Chen; Yawah T Nicholson; Brian R Rosborough; Angus W Thomson; Giorgio Raimondi
Journal:  J Immunol       Date:  2016-07-11       Impact factor: 5.422

7.  NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.

Authors:  Pedro I Lucena; Douglas V Faget; Emilia Pachulec; Marcela C Robaina; Claudete E Klumb; Bruno K Robbs; João P B Viola
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

Review 8.  Transcriptional regulatory networks for CD4 T cell differentiation.

Authors:  Darah Christie; Jinfang Zhu
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

9.  Utility of IL-2 Complexes in Promoting the Survival of Murine Orthotopic Forelimb Vascularized Composite Allografts.

Authors:  Heng Xu; Satinder Dahiya; Liqing Wang; Tatiana Akimova; Rongxiang Han; Tianyi Zhang; Yixin Zhang; Ling Qin; Matthew H Levine; Wayne W Hancock; L Scott Levin
Journal:  Transplantation       Date:  2018-01       Impact factor: 4.939

Review 10.  Impact of Immune-Modulatory Drugs on Regulatory T Cell.

Authors:  Akiko Furukawa; Steven A Wisel; Qizhi Tang
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.